Oncolytics Biotech (ONCY) Amortization - Intangibles (2009 - 2010)
Oncolytics Biotech (ONCY) posted quarterly Amortization - Intangibles of -$7.2 million for Q4 2010, down 300.0% quarter-over-quarter from $3.6 million in Q3 2010.
Oncolytics Biotech (ONCY) Amortization - Intangibles (2009 - 2010) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Amortization - Intangibles for 2 consecutive years, with -$7.2 million the latest figure, recorded in Q4 2010.
- In Q4 2010, Amortization - Intangibles changed N/A year-over-year to -$7.2 million; the TTM figure through Dec 2010 stood at $3.6 million (down 4.76% YoY), while the FY2010 annual figure was $3.6 million, up 1900.0% from the prior year.
- Amortization - Intangibles declined to -$7.2 million in Q4 2010 per ONCY's latest filing, from $3.6 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $3.6 million in Q3 2009 and bottomed at -$7.2 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oncolytics Biotech | 101.16 Mn | 101.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -7.23 Mn |
| Sep 30, 2010 | 3.62 Mn |
| Jun 30, 2010 | 3.62 Mn |
| Mar 31, 2010 | 3.62 Mn |
| Sep 30, 2009 | 3.62 Mn |
| Jun 30, 2009 | 90,375.00 |
| Mar 31, 2009 | 90,375.00 |